Maravai LifeSciences Holdings, Inc. MRVI Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Revenue by Business | |||||
| Cygnus | $65.96M+5.0% | $62.84M-2.1% | $64.18M-8.2% | $69.93M+2.2% | |
| TriLink | $119.79M-39.0% | $196.35M-12.6% | $224.77M-72.4% | $813.08M+14.1% | |
| Revenue by Geography | |||||
| Asia Pacific | $41.47M-53.6% | $89.38M-8.3% | $97.44M-11.3% | $109.79M+31.2% | |
| Europe, the Middle East and Africa | $30.92M-26.5% | $42.06M-15.8% | $49.92M-88.5% | $432.93M+8.9% | |
| Latin and Central America | $971K+46.7% | $662K+25.6% | $527K-34.8% | $808K-4.0% | |
| North America | $112.38M-11.6% | $127.09M-9.9% | $141.06M-58.4% | $339.47M+7.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Maravai LifeSciences Holdings, Inc. break its business down?
- Maravai LifeSciences Holdings, Inc. (MRVI) reports revenue by business across 2 parts — Cygnus and TriLink. Each is extracted from the segment footnotes and tracked over time.
- Where does Maravai LifeSciences Holdings, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Maravai LifeSciences Holdings, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
